KKM Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16M Sell
13,652
-289
-2% -$295K 2.19% 4
2026
Q1
$15M Hold
13,941
2.66% 4
2025
Q4
$15M Buy
13,941
+9,135
+190% +$8.73M 2.66% 4
2025
Q3
$3.67M Buy
4,806
+718
+18% +$534K 1.15% 44
2025
Q2
$3.19M Buy
4,088
+1,017
+33% +$790K 1.11% 39
2025
Q1
$2.54M Sell
3,071
-256
-8% -$213K 1.07% 38
2024
Q4
$2.57M Buy
3,327
+386
+13% +$320K 1.07% 40
2024
Q3
$2.61M Buy
2,941
+222
+8% +$200K 1.29% 29
2024
Q2
$2.46M Buy
2,719
+85
+3% +$68K 1.16% 30
2024
Q1
$2.05M Buy
+2,634
New +$1.87M 1% 43

Other funds holding LLY

KKM Financial's LLY Position: Q2 2026 in Review

KKM Financial reduced its Eli Lilly (LLY) stake by 2.1% in Q2 2026, selling an estimated $295K and leaving 13,652 shares worth $16M. The position accounts for 2.19% of the portfolio, ranked #4.

KKM Financial first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • KKM Financial held 13,652 shares of Eli Lilly worth $16M as of Q2 2026.
  • KKM Financial sold 289 Eli Lilly shares in Q2 2026, an estimated $295K.
  • Eli Lilly made up 2.19% of KKM Financial's portfolio in Q2 2026, its #4 holding.
  • KKM Financial first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on KKM Financial's 13F filing for Q2 2026, filed 14 Aug 2026.